0000899243-18-006551.txt : 20180306 0000899243-18-006551.hdr.sgml : 20180306 20180306202752 ACCESSION NUMBER: 0000899243-18-006551 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180302 FILED AS OF DATE: 20180306 DATE AS OF CHANGE: 20180306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Malik Rajiv CENTRAL INDEX KEY: 0001388111 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 333-199861 FILM NUMBER: 18671671 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE, SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mylan N.V. CENTRAL INDEX KEY: 0001623613 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981189497 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL BUSINESS PHONE: 44 0 1707 853 000 MAIL ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL FORMER COMPANY: FORMER CONFORMED NAME: New Moon B.V. DATE OF NAME CHANGE: 20141028 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-02 0 0001623613 Mylan N.V. MYL 0001388111 Malik Rajiv BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL UNITED KINGDOM 1 1 0 0 President Ordinary Shares 2018-03-02 4 S 0 50000 40.9139 D 503751 D Ordinary Shares 2018-03-03 4 M 0 12395 0.00 A 516146 D Ordinary Shares 2018-03-03 4 F 0 5472 40.97 D 510674 D Ordinary Shares 2018-03-04 4 M 0 5264 0.00 A 515938 D Ordinary Shares 2018-03-04 4 F 0 2324 40.97 D 513614 D Ordinary Shares 2018-03-04 4 M 0 35532 0.00 A 549146 D Ordinary Shares 2018-03-04 4 F 0 14977 40.97 D 534169 D Ordinary Shares 250000 I By Grantor Retained Annuity Trust Employee Stock Option - Right to Buy 40.97 2018-03-02 4 A 0 71600 0.00 A 2028-03-02 Ordinary Shares 71600 71600 D Restricted Stock Units 0.00 2018-03-02 4 A 0 43935 0.00 A Ordinary Shares 43935 43935 D Restricted Stock Units 0.00 2018-03-03 4 M 0 12395 0.00 D Ordinary Shares 12395 24790 D Restricted Stock Units 0.00 2018-03-04 4 M 0 5264 0.00 D Ordinary Shares 5264 0 D Performance Restricted Stock Units 0.00 2018-03-04 4 M 0 35532 0.00 D Ordinary Shares 35532 0 D Represents the weighted average price of the reporting person's disposition of 50,000 shares in transactions ranging from $40.78 to $41.13. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote. Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 3, 2017. Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on November 17, 2015. Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of the performance restricted stock units (PRSUs) granted on November 17, 2015. 23,867 of the options will vest on March 2, 2019, 23,866 will vest on March 2, 2020, and 23,867 will vest on March 2, 2021. The options expire on March 2, 2028. Each RSU represents the right to receive one ordinary share of Mylan N.V. The RSUs vest in three equal annual installments beginning on March 2, 2019. Each RSU represents the right to receive one ordinary share of Mylan N.V. 12,395 of the RSUs granted on March 3, 2017 vested on March 3, 2018, and 12,395 will vest on each of March 3, 2019 and March 3, 2020. Each RSU represents the right to receive one ordinary share of Mylan N.V. 5,264 of the RSUs granted on November 17, 2015 vested on each of March 4, 2016, March 4, 2017, and March 4, 2018. Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on November 17, 2015, subject to the attainment of previously established two-year performance goals and a vesting period. The PRSUs fully vested on March 4, 2018. /s/ Kevin Macikowski, by power of attorney 2018-03-06